Kline T - Search Results

1

Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activity.

Leftheris K, Kline T, Vite GD, Cho YH, Bhide RS, Patel DV, Patel MM, Schmidt RJ, Weller HN, Andahazy ML, Carboni JM, Gullo-Brown JL, Lee FY, Ricca C, Rose WC, Yan N, Barbacid M, Hunt JT, Meyers CA, Seizinger BR, Zahler R, Manne V. Leftheris K, et al. Among authors: kline t. J Med Chem. 1996 Jan 5;39(1):224-36. doi: 10.1021/jm950642a. J Med Chem. 1996. PMID: 8568812

2

A pseudopeptide incorporating the tetrahydrophthalazine nucleus, a constrained aza analog of phenylalanine.

Kline T, Mueller L, Sieber-McMaster E, Lau WF, Meyers CA. Kline T, et al. Int J Pept Protein Res. 1996 Mar;47(3):142-7. doi: 10.1111/j.1399-3011.1996.tb01337.x. Int J Pept Protein Res. 1996. PMID: 8740962

3

Investigation of conformational specificity at GPIIb/IIIa: evaluation of conformationally constrained RGD peptides.

Peishoff CE, Ali FE, Bean JW, Calvo R, D'Ambrosio CA, Eggleston DS, Hwang SM, Kline TP, Koster PF, Nichols A, et al. Peishoff CE, et al. Among authors: kline tp. J Med Chem. 1992 Oct 16;35(21):3962-9. doi: 10.1021/jm00099a026. J Med Chem. 1992. PMID: 1433203

4

NMR study on solution structure of the site-specific mutant Leu48----Ala transforming growth factor alpha.

Kline TP, Mueller L. Kline TP, et al. Int J Pept Protein Res. 1992 Feb;39(2):111-6. doi: 10.1111/j.1399-3011.1992.tb00779.x. Int J Pept Protein Res. 1992. PMID: 1517010

5

Solution structures of human transforming growth factor alpha derived from 1H NMR data.

Kline TP, Brown FK, Brown SC, Jeffs PW, Kopple KD, Mueller L. Kline TP, et al. Biochemistry. 1990 Aug 28;29(34):7805-13. doi: 10.1021/bi00486a005. Biochemistry. 1990. PMID: 2261437

6

Structure-function analysis of human transforming growth factor-alpha by site-directed mutagenesis.

Feild JA, Reid RH, Rieman DJ, Kline TP, Sathe G, Greig RG, Anzano MA. Feild JA, et al. Among authors: kline tp. Biochem J. 1992 Apr 1;283 ( Pt 1)(Pt 1):91-8. doi: 10.1042/bj2830091. Biochem J. 1992. PMID: 1567383 Free PMC article.

7

Structure of the hirulog 3-thrombin complex and nature of the S' subsites of substrates and inhibitors.

Qiu X, Padmanabhan KP, Carperos VE, Tulinsky A, Kline T, Maraganore JM, Fenton JW 2nd. Qiu X, et al. Among authors: kline t. Biochemistry. 1992 Dec 1;31(47):11689-97. doi: 10.1021/bi00162a004. Biochemistry. 1992. PMID: 1445905

8

Hirulog peptides with scissile bond replacements resistant to thrombin cleavage.

Kline T, Hammond C, Bourdon P, Maraganore JM. Kline T, et al. Biochem Biophys Res Commun. 1991 Jun 28;177(3):1049-55. doi: 10.1016/0006-291x(91)90644-m. Biochem Biophys Res Commun. 1991. PMID: 2059196

9

NMR studies of an oligonucleotide with an unusual structure induced by platinum anti-cancer drugs.

Kline TP, Marzilli LG, Live D, Zon G. Kline TP, et al. Biochem Pharmacol. 1990 Jul 1;40(1):97-113. doi: 10.1016/0006-2952(90)90184-m. Biochem Pharmacol. 1990. PMID: 2372316

10

Outcomes of substance use and sexual power among adolescent girls and young women in Cape Town: Implications for structural and cultural differences.

Wechsberg WM, Browne FA, Carney T, Kline TL, Howard BN, Russell SE, van der Drift I, Myers B, Minnis AM, Bonner CP, Ndirangu JW. Wechsberg WM, et al. Among authors: kline tl. Glob Public Health. 2024 Jan;19(1):2340500. doi: 10.1080/17441692.2024.2340500. Epub 2024 Apr 16. Glob Public Health. 2024. PMID: 38628080 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

358 results

Search Page